Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

790 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Burden of multimorbidity in a Polish cohort of ambulatory and hospitalized heart failure patients from 2 large European registry programs: prognostic implications.
Sierpiński R, Franczuk P, Tkaczyszyn M, Suchocki T, Krekora J, Opolski G, Maggioni A, Poloński L, Ponikowski P, Jankowska EA. Sierpiński R, et al. Among authors: opolski g. Pol Arch Intern Med. 2021 Nov 30;131(11):16101. doi: 10.20452/pamw.16101. Epub 2021 Sep 29. Pol Arch Intern Med. 2021. PMID: 34585879 Free article.
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction.
Køber L, Swedberg K, McMurray JJ, Pfeffer MA, Velazquez EJ, Diaz R, Maggioni AP, Mareev V, Opolski G, Van de Werf F, Zannad F, Ertl G, Solomon SD, Zelenkofske S, Rouleau JL, Leimberger JD, Califf RM. Køber L, et al. Among authors: opolski g. Eur J Heart Fail. 2006 Oct;8(6):591-8. doi: 10.1016/j.ejheart.2005.11.007. Epub 2006 Feb 28. Eur J Heart Fail. 2006. PMID: 16507350 Free article. Clinical Trial.
Resistance to oral antiplatelet drugs--a Position Paper of the Working Group on antiplatelet drug resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society.
Kuliczkowski W, Witkowski A, Watala C, Filipiak KJ, Budaj A, Golanski J, Sitkiewicz D, Pregowski J, Gorski J, Zembala M, Opolski G, Polonski L; Working Group on antiplatelet drug resistance of the Polish Cardiac Society. Kuliczkowski W, et al. Among authors: opolski g. Kardiol Pol. 2008 Apr;66(4):470-6, 480-5. Kardiol Pol. 2008. PMID: 18473281 English, Polish. No abstract available.
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology.
Kuliczkowski W, Witkowski A, Polonski L, Watala C, Filipiak K, Budaj A, Golanski J, Sitkiewicz D, Pregowski J, Gorski J, Zembala M, Opolski G, Huber K, Arnesen H, Kristensen SD, De Caterina R. Kuliczkowski W, et al. Among authors: opolski g. Eur Heart J. 2009 Feb;30(4):426-35. doi: 10.1093/eurheartj/ehn562. Epub 2009 Jan 27. Eur Heart J. 2009. PMID: 19174428 Review.
Demographic and clinical characteristics of patients with atrial fibrillation and cardioversion as planned therapeutic options in the International Registry on Cardioversion of Atrial Fibrillation RHYTHM-AF Polish substudy.
Dąbrowski R, Opolski G, Włodarczyk P, Kiliszek M, Ponikowski P. Dąbrowski R, et al. Among authors: opolski g. Kardiol Pol. 2014;72(8):700-6. doi: 10.5603/KP.a2014.0067. Epub 2014 Mar 27. Kardiol Pol. 2014. PMID: 24671916 Free article.
Cardiology in Poland: a 60-year perspective.
Jankowska EA, Kalarus Z, Opolski G. Jankowska EA, et al. Among authors: opolski g. Eur Heart J. 2014 May 21;35(20):1299-301. Eur Heart J. 2014. PMID: 24971444 No abstract available.
790 results